Clinical Research Directory
Browse clinical research sites, groups, and studies.
Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis
Sponsor: Beth Israel Deaconess Medical Center
Summary
This is a randomized, double-blind, placebo-controlled trial to determine if administration of intravenous thiamine will lead to quicker resolution of acidosis in patients admitted to the hospital with diabetic ketoacidosis. The investigators will secondarily investigate whether thiamine improves cellular oxygen consumption, shortens intensive care unit (ICU) and hospital stay or decreases hospital resource utilization.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
102
Start Date
2018-11-21
Completion Date
2024-10-01
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Interventions
200mg IV thiamine in 50mL 0.9% saline
Thiamine 200mg IV every 12 hours for 2 days
Placebo
50mL 0.9% saline
Locations (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States